What is the likelihood that the initial diagnosis of CKD stage 2 was incorrect, and do I currently have CKD with an eGFR of approximately 64, in the absence of evidence of kidney damage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Was the Initial CKD Stage 2 Diagnosis Incorrect?

The initial diagnosis of CKD stage 2 was likely incorrect because CKD stages 1 and 2 absolutely require documented evidence of kidney damage (such as albuminuria, imaging abnormalities, or biopsy findings) in addition to the eGFR value—an eGFR of 60-89 mL/min/1.73 m² alone is insufficient for diagnosis. 1, 2, 3

Understanding the Diagnostic Requirements

CKD Stage 2 Criteria

  • Stage 2 CKD requires BOTH components: eGFR 60-89 mL/min/1.73 m² AND evidence of kidney damage persisting for at least 3 months 1, 3
  • Evidence of kidney damage includes:
    • Albuminuria (UACR ≥30 mg/g creatinine) 1
    • Glomerular hematuria 1
    • Radiographic abnormalities 1
    • Pathological findings on biopsy 1

The Critical Diagnostic Error

  • The most common misdiagnosis occurs when clinicians diagnose CKD based on eGFR alone without confirming kidney damage 2, 3
  • Your nephrologist appears to have made this exact error if no evidence of kidney damage was documented 2

Do You Currently Have CKD?

With eGFR of 64 mL/min/1.73 m²

You do NOT have CKD if there is no evidence of kidney damage, as your eGFR of 64 mL/min/1.73 m² falls within the stage 2 range (60-89 mL/min/1.73 m²), which requires additional proof of kidney damage for diagnosis. 3, 4

Important Considerations About eGFR Fluctuations

  • eGFR variability is common and does not necessarily indicate disease progression or improvement 1
  • Your eGFR fluctuations (60s → upper 50s → 60s-70s → 64) suggest:
    • Biological variability in creatinine production 1
    • Hydration status effects 1
    • Measurement variability 1
    • Potential inaccuracy of creatinine-based equations 4

The 3-Month Rule for Chronicity

  • CKD diagnosis requires abnormalities persisting for at least 3 months 1, 4
  • A single abnormal eGFR could represent:
    • Acute kidney injury 1
    • Acute kidney disease 2
    • Temporary physiological variation 1

Addressing Your Specific Questions

Did You Have CKD Stage 3a?

No, you did not have CKD stage 3a when your eGFR fell to the upper 50s. While stage 3a is defined as eGFR 45-59 mL/min/1.73 m², this stage can be diagnosed by eGFR alone only if it persists for >3 months. 3, 4 However, since your eGFR subsequently improved back to the 60s-70s, this was likely:

  • Temporary physiological variation 1
  • Measurement error 1
  • Reversible acute kidney disease 1

Did You Ever Have CKD?

Based on the information provided—that there was "absolutely no evidence of kidney damage"—you never had CKD. 2, 3 The diagnosis was based solely on eGFR values in the 60s, which is insufficient for CKD stage 2 diagnosis. 1

What Should Have Been Done

Proper Diagnostic Workup

  • Measure urine albumin-to-creatinine ratio (UACR) on at least 2 of 3 specimens over 3-6 months 1
  • Obtain kidney imaging (ultrasound) to assess for structural abnormalities 1
  • Review past eGFR measurements to establish chronicity 2, 4
  • Consider measuring cystatin C to confirm eGFR accuracy, especially if eGFR is 45-59 mL/min/1.73 m² 4

Confirming True CKD vs. Normal Aging

  • In individuals ≥70 years, an eGFR of 45-59 mL/min/1.73 m² that is stable over time without other evidence of kidney damage may represent normal aging rather than CKD 5
  • The controversy exists whether eGFR <60 mL/min/1.73 m² alone should define CKD, particularly in elderly individuals 1

Common Pitfalls to Avoid

  • Never diagnose CKD stages 1-2 based on eGFR alone 2, 3
  • Do not assume a single abnormal eGFR represents chronic disease 2, 4
  • Recognize that eGFR equations have limitations in certain populations (elderly, extreme body composition, variable muscle mass) 1, 4
  • Understand that biological variability can cause eGFR fluctuations of 10-15% without true change in kidney function 1

Current Recommendation

Request documentation from your nephrologist regarding evidence of kidney damage (UACR results, imaging findings, or biopsy results). If no such evidence exists and your eGFR remains ≥60 mL/min/1.73 m², you do not meet criteria for CKD and the diagnosis should be reconsidered. 2, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of CKD Stage 2

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Classification of Chronic Kidney Disease Stages

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chronic Kidney Disease Diagnosis and Staging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What does an estimated glomerular filtration rate (eGFR) of 58, indicating stage 3a chronic kidney disease (CKD), imply for my diagnosis and management, given the reference range for normal eGFR is typically above 60?
What stage of chronic kidney disease corresponds to an estimated Glomerular Filtration Rate (eGFR) of 38?
What is the best course of action for managing impaired renal function with elevated creatinine and decreased eGFR?
What is the eGFR of a 70-year-old male with serum creatinine of 1.9 mg/dL?
How to manage a 35-year-old male with Chronic Kidney Disease (CKD) and impaired renal function?
What is the recommended treatment for a pregnant woman with a common cold?
What are the guidelines for initiating MIRCERA (methoxy polyethylene glycol-epoetin beta) in a patient with chronic kidney disease and anemia, including dosing and monitoring parameters?
What is the initial approach for a patient presenting with a pleomorphic sarcoma at the gastroesophageal junction (GEJ) mimicking pseudoachalasia?
How do amphetamines affect blood pressure in patients, particularly those with pre-existing hypertension or at risk for cardiovascular disease?
At what blood pressure level should MIRCERA (methoxy polyethylene glycol-epoetin beta) be held in a patient with chronic kidney disease and anemia?
What is the likely diagnosis and treatment disadvantage for a patient with a history of nerve damage from a laxative overdose a few years ago, presenting with symptoms of neuropathic pain or pelvic floor dysfunction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.